Director: Nam Tran, Ph.D.
The mission of the UC Davis Pathology Biorepository is to provide high quality, well-characterized cancer-related human tissue specimens and biological materials to collaborators.
The specific objectives of the shared resource are:
- The procurement, preparation and preservation of malignant, benign, and normal human specimens in a centralized repository
- To provide high quality annotated data (pathological and clinical) using a secure and interactive database system
- To facilitate compliance with all mandated regulatory processes (IRB, HIPAA, SRC) thereby promoting ethical research by UC Davis researchers
- To provide pathologic consultation to investigators using human specimens for scientific correlation
- To efficiently prioritize, disperse and track specimens via a rapid and standardized approval and monitoring process
- To provide TMA consultation and services for cancer center investigators and their collaborators
This facility offers several advantages over other national specimen repositories. They include:
- Specimens are processed according to researcher specifications
- The location at the UC Davis Medical Center is convenient
- Surgical pathologists oversee tissue procurement
- De-identified clinical information is available
- Investigators, surgeons, clinicians, oncologists and surgical pathologists have opportunities for collaboration
Skilled personnel work with surgeons, pathologists, and researchers to maximize the scientific value of the acquired tissue without compromising diagnostic processing. The pathologist leader oversees designation of diagnostic histologic sections so investigators can correlate pathologic features with their data. In addition, the Biorepository provides investigators access to histopathologic parameters available from the final diagnostic report while preserving individual patient confidentiality.
NOTICE TO ALL NIH-FUNDED INVESTIGATORS
This resource is funded by the UC Davis Comprehensive Cancer Center Support Grant (CCSG) awarded by the National Cancer Institute (NCI P30CA093373). Publications that have utilized facility resources, services or scientific data generated by the resource should acknowledge the resource or the assistance provided by resource staff and cite the NCI CCSG grant. An electronic copy of the publication should also be sent to the resource directors.